Atlas Trials

Safety, Tolerability and Pharmacokinetics of EM-I-2024

Clinical trial NCT07584668 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07584668
Sponsor
National Medical Research Radiological Centre of the Ministry of Health of Russia
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Assess the Safety and Tolerability of Various Doses and Dosing Schedules of EnteroMix in Patients With a Histologically Confirmed Solid Tumor
Start date
2025-07-30
Primary completion
2026-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.